NEW YORK, NY / ACCESSWIRE / November 19, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Endochoice Holdings Inc. (NYSE: GI), Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX), Aquinox Pharmaceuticals Inc. (NASDAQ: AQXP) and ARC Document Solutions Inc. (NYSE: ARC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
GI Research Package: http://www.traders-choice.com/pdf?s=GI
CPRX Research Package: http://www.traders-choice.com/pdf?s=CPRX
AQXP Research Package: http://www.traders-choice.com/pdf?s=AQXP
ARC Research Package: http://www.traders-choice.com/pdf?s=ARC
============
Highlights from today's reports include:
On Wednesday, November 18, 2015, the NASDAQ Composite ended at 5,075.20, up 1.79%, the Dow Jones Industrial Average advanced 1.42%, to finish the day at 17,737.16, and the S&P 500 closed at 2,083.58, up 1.62%.
- In line with the broad market, Endochoice Holdings Inc.'s stock added 0.79% to close Wednesday's session at USD 8.93. The company's shares oscillated between USD 8.65 and USD 9.07. The stock recorded a trading volume of 0.06 million shares, which was below its 50-day daily average volume of 0.17 million shares and below its 52-week average volume of 0.19 million shares. Over the last one week, Endochoice Holdings Inc.'s shares have declined by 0.45% and in the past one month, it has lost 22.08%. Further, the stock is trading at a price to book (mrq) ratio of 1.99x and price to sales (ttm) of 3.05x. The company has market capitalization of USD 221.42 million. ECPM Holdings, LLC is a medical device company, focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers.
- Catalyst Pharmaceuticals Inc.'s stock declined 6.72% to close Wednesday's session at USD 2.50. The share price vacillated between USD 2.47 and USD 2.67 marking a new 52-week low during the session. The stock recorded a trading volume of 1.19 million shares, which was above its 50-day daily average volume of 0.60 million shares and above its 52-week average volume of 0.78 million shares. Over the last three days Catalyst Pharmaceuticals Inc.'s shares have declined by 9.42% and in the past one week it has moved down 16.67%. Further, the stock is trading at a price to book ratio of 3.65x compared to historical PB ratio of 5.82x. Moreover, the company is trading below its 50-day moving average of USD 3.13. Catalyst Pharmaceuticals Inc. has market capitalization of USD 207.06 million. Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a biopharmaceutical company focused on developing and commercializing therapies for people with rare debilitating diseases.
- Aquinox Pharmaceuticals Inc.'s stock edged lower by 0.48% to close Wednesday's session at USD 12.43. The company's shares oscillated between USD 12.08 and USD 12.55. The stock recorded a trading volume of 0.11 million shares, which was below its 50-day daily average volume of 0.47 million shares and below its 52-week average volume of 0.59 million shares. Over the last three months, the stock has lost 27.86% but in the past six months, the shares have picked up 67.07%. Furthermore, on a compounded total return basis, the company has returned 50.30% in the past one year. The company is trading below its 50-day moving average of USD 14.07, but above its 200-day moving average of USD 10.98. Additionally, the stock is trading at a price to book (mrq) ratio of 5.19x. Aquinox Pharmaceuticals Inc. has market capitalization of USD 213.95 million.
- The stock of ARC Document Solutions Inc. gained 2.99% to close Wednesday's session at USD 4.82. The shares of the company moved in the range of USD 4.61 and USD 4.83 marking a new 52-week low during the session. A trading volume of 0.23 million shares was recorded, which was greater than its 150-day daily average volume of 0.22 million shares and below its 52-week average volume of 0.24 million shares. Over the last three days, ARC Document Solutions Inc.'s shares have gained by 0.42% while in the past one month, it has lost 20.98%. Further, the company is trading at a price to earnings ratio of 2.51x and at a price to book ratio of 1.11x. This compares to a historical PE ratio of 66.15x and historical PB ratio of 4.65x. Further, the stock is trading at a price to cash flow ratio of 3.45x and price to sales ratio of 0.51x. ARC Document Solutions Inc. has market capitalization of USD 226.50 million.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE:Trader's Choice
